282 related articles for article (PubMed ID: 21426216)
1. Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
Jones VM; Moore KA; Peterson DM
J Pain Palliat Care Pharmacother; 2011; 25(1):32-41. PubMed ID: 21426216
[TBL] [Abstract][Full Text] [Related]
2. Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia.
Wallace M; Pappagallo M
Expert Rev Neurother; 2011 Jan; 11(1):15-27. PubMed ID: 21158551
[TBL] [Abstract][Full Text] [Related]
3. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.
Backonja MM; Malan TP; Vanhove GF; Tobias JK;
Pain Med; 2010 Apr; 11(4):600-8. PubMed ID: 20113411
[TBL] [Abstract][Full Text] [Related]
4. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
[TBL] [Abstract][Full Text] [Related]
5. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
[TBL] [Abstract][Full Text] [Related]
6. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia.
Irving G; Backonja M; Rauck R; Webster LR; Tobias JK; Vanhove GF
Clin J Pain; 2012 Feb; 28(2):101-7. PubMed ID: 21753727
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).
Katz NP; Mou J; Paillard FC; Turnbull B; Trudeau J; Stoker M
Clin J Pain; 2015 Oct; 31(10):859-66. PubMed ID: 25503598
[TBL] [Abstract][Full Text] [Related]
8. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
Webster LR; Tark M; Rauck R; Tobias JK; Vanhove GF
BMC Neurol; 2010 Oct; 10():92. PubMed ID: 20937130
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database.
Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
Pain; 2013 Sep; 154(9):1632-1639. PubMed ID: 23707278
[TBL] [Abstract][Full Text] [Related]
10. [Effective pain relief of post-herpetic neuralgia with capsaicin patch].
Andersen HH; Sand C; Elberling J
Ugeskr Laeger; 2016 Feb; 178(5):V10150846. PubMed ID: 26857302
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
Simpson DM; Gazda S; Brown S; Webster LR; Lu SP; Tobias JK; Vanhove GF;
J Pain Symptom Manage; 2010 Jun; 39(6):1053-64. PubMed ID: 20538187
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
Burness CB; McCormack PL
Drugs; 2016 Jan; 76(1):123-34. PubMed ID: 26666418
[TBL] [Abstract][Full Text] [Related]
13. Capsaicin patch (Qutenza) for postherpetic neuralgia.
Med Lett Drugs Ther; 2011 May; 53(1365):42-3. PubMed ID: 21617594
[TBL] [Abstract][Full Text] [Related]
14. An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.
Simpson DM; Estanislao L; Brown SJ; Sampson J
J Pain Symptom Manage; 2008 Mar; 35(3):299-306. PubMed ID: 17959343
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
Irving GA; Backonja MM; Dunteman E; Blonsky ER; Vanhove GF; Lu SP; Tobias J;
Pain Med; 2011 Jan; 12(1):99-109. PubMed ID: 21087403
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia.
Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV
Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358
[TBL] [Abstract][Full Text] [Related]
17. Capsaicin. Neuropathic pain: playing with fire...
Prescrire Int; 2010 Aug; 19(108):153-5. PubMed ID: 20939441
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
Webster LR; Malan TP; Tuchman MM; Mollen MD; Tobias JK; Vanhove GF
J Pain; 2010 Oct; 11(10):972-82. PubMed ID: 20655809
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.
Martini CH; Yassen A; Krebs-Brown A; Passier P; Stoker M; Olofsen E; Dahan A
Eur J Pain; 2013 Nov; 17(10):1491-501. PubMed ID: 23650124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
